학술논문
SARS-CoV-2-neutralising antibody BGB-DXP593 in mild-to-moderate COVID-19: a multicentre, randomised, double-blind, phase 2 trial
Document Type
Article
Author
Source
In: eClinicalMedicine . (eClinicalMedicine, March 2023, 57)
Subject
Language
English
ISSN
25895370